PHARMACODYNAMICS AND PHARMACOKINETICS OF VELITEN(R) (RUTINE, ALPHA-TOCOPHEROL AND ASCORBIC-ACID) IN PATIENTS WITH CHRONIC VENOUS INSUFFICIENCY

Citation
A. Auteri et al., PHARMACODYNAMICS AND PHARMACOKINETICS OF VELITEN(R) (RUTINE, ALPHA-TOCOPHEROL AND ASCORBIC-ACID) IN PATIENTS WITH CHRONIC VENOUS INSUFFICIENCY, International journal of clinical pharmacology research, 14(3), 1994, pp. 95-100
Citations number
6
Categorie Soggetti
Pharmacology & Pharmacy
ISSN journal
02511649
Volume
14
Issue
3
Year of publication
1994
Pages
95 - 100
Database
ISI
SICI code
0251-1649(1994)14:3<95:PAPOV(>2.0.ZU;2-E
Abstract
The aim of this study was to evaluate the pharmacodynamics and pharmac okinetics of a single oral dose of Veliten(R) in 12 patients affected by chronic venous insufficiency. In particular, the pharmacokinetics o f two components of Veliten(R), namely rutine and alpha-tocopherol, we re considered, while with respect to pharmacodynamics, studies were ma de of venous function, haemocoagulative and fibrinolytic balance, and haemorheological parameters. Correlation between such changes and plas ma drug levels was also evaluated. We found a significant increase of venous tone, venous capacity and venous distension after drug intake, as well as a significant activation of fibrinolysis (globally evaluate d with euglobulin lysis time), related to a slight increase of plasmin ogen tissue activator. These changes appeared concomitantly with maxim al plasma levels of rutine. We did not find any modifications of coagu lative and haemorheological parameters.